beaker
 

Products

 

Zurex Pharma, Inc. Publications:

 

Infection Control & Hospital Epidemiology

Infection Control & Hospital Epidemiology
Alternatives to skin preparation with conventional preoperative antiseptics are required because of adverse reactions and the potential emergence of resistance. Here, we present 2 phase 2 studies of ZuraGard (ZG), a novel formulation of isopropyl alcohol and functional excipients developed for preoperative skin antisepsis.

 

Journal of Critical Care Medicine

AZEPTIC Trial -
Journal of Critical Care Medicine 2011

A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: A multi-center, controlled, randomized trial

Journal of Critical Care Medicine

Journal of Antimicrobial Chemotherapy 2009
Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions

Journal of Critical Care Medicine

Journal of Infection 2010
In vitro and in vivo evaluation of efficacy of citrate/methylene blue/parabens/IPA solution as a skin disinfectant

Journal of Critical Care Medicine

Nephrology Dialysis Transplantation 2009
Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens)

Zuragard™

Presurgical skin preparation
for the prevention of surgical
site infections.

Patient Bathing

Novel, highly effective, anti-septic patient bathing and hand hygiene products are in the works.

Wound Care

Post-surgical solutions for the prevention of surgical site infections and wound management.
ZurAsept

ZurAsept™

Prevention of intra-luminal catheter-related bloodstream infections in central line catheters.

Zurex Product Line

Our goal is to provide safe and effective anti-microbial products designed to reduce the risks associated with health care-associated infections with a focus on surgical site wounds and catheter-related bloodstream infections (CRBSI).